Hofseth BioCare ASA (LON:0Q6H)

Market Cap	57.85M
Revenue (ttm)	18.67M
Net Income (ttm)	-8.68M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98
Average Volume	72,495
Open	0.141
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.116 - 0.169
Beta	0.57
RSI	34.46
Earnings Date	May 16, 2025

About Hofseth BioCare ASA

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 200...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2000
• Employees: 71
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q6H

Financial Performance

In 2024, Hofseth BioCare ASA's revenue was 265.54 million, an increase of 21.52% compared to the previous year's 218.51 million. Losses were -123.41 million, 15.7% more than in 2023.

Financial numbers in NOK